FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

768331000: Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3709902015 Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3709903013 Ethinyl estradiol- and norelgestromin-containing product in transdermal dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3709904019 Ethinylestradiol- and norelgestromin-containing product in transdermal dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ethinylestradiol true Inferred relationship Some 1
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) Is a Product containing ethinylestradiol and norelgestromin (medicinal product) true Inferred relationship Some
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Norelgestromin (substance) true Inferred relationship Some 2
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) Has manufactured dose form Transdermal dose form (dose form) true Inferred relationship Some
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) Is a Product manufactured as transdermal dose form (product) true Inferred relationship Some
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) Is a Estradiol-containing product in transdermal dose form false Inferred relationship Some
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) Plays role Contraceptive therapeutic role (role) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
ethynylestradiol 0,02 mg + norelgestromin 0,15 mg pr. dag depotplaster Is a False Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) Inferred relationship Some
Ethinylestradiol and norelgestromin only product in transdermal dose form Is a True Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start